Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Aiach

Showing results (111-120 of 236) with videos related to

Pageof 24
Sort By:
Thrombosis and Haemostasis|August 30, 1988
Antithrombin III Avranches, a new variant with defective serine-protease inhibition--comparison with antithrombin III CharlevilleM Aiach, M Roncato, G Chadeuf, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|April 20, 1975
Discontinued thrombolytic treatment: initial biological resultsM Aiach, J N Fiessinger, M Devanlay, et al.
Thrombosis and Haemostasis|June 30, 1981
Effect of local urokinase on arterial occlusion of lower limbsJ N Fiessinger, M Aiach, L Capron, et al.
Thrombosis and Haemostasis|April 8, 1998
Importance of the FcgammaRIIa-Arg/His-131 polymorphism in heparin-induced thrombocytopenia diagnosisC Bachelot-Loza, R Saffroy, D Lasne, et al.
Thrombosis and Haemostasis|February 26, 1982
Kinetic study of factor X during oral anticoagulation with acenocoumarol: potential value for the initiation of treatmentM Aiach, J N Fiessinger, L Capron, et al.
Journal of Thrombosis and Haemostasis : JTH|June 29, 2006
The angiopoietin pathway is modulated by PAR-1 activation on human endothelial progenitor cellsD M Smadja, I Laurendeau, C Avignon, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|January 14, 1973
[Prostate cancer and disseminated intravascular blood coagulation]H Durand, M Aiach, J Belaiche, et al.
Thrombosis and Haemostasis|February 28, 1986
Heparin-associated thrombocytopenia treatment with low molecular weight heparinJ F Vitoux, J F Mathieu, M Roncato, et al.
Transfusion|October 1, 1994
Influence of a 12-hour, 22 degrees C holding period for buffy coats on the preparation of platelet concentrates stored in plasmaN Boeri, S Saleun, E Pelissier, et al.
La Revue De Medecine Interne|May 1, 1986
[Fatal cerebellar embolism during the in situ thrombolytic treatment of an acute arterial obstruction]J F Vitoux, J N Fiessinger, J M Pernès, et al.
Pageof 24

Showing results (111-120 of 236) with videos related to

Sort By:
Pageof 24
Thrombosis and Haemostasis|August 30, 1988
Antithrombin III Avranches, a new variant with defective serine-protease inhibition--comparison with antithrombin III CharlevilleM Aiach, M Roncato, G Chadeuf, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|April 20, 1975
Discontinued thrombolytic treatment: initial biological resultsM Aiach, J N Fiessinger, M Devanlay, et al.
Thrombosis and Haemostasis|June 30, 1981
Effect of local urokinase on arterial occlusion of lower limbsJ N Fiessinger, M Aiach, L Capron, et al.
Thrombosis and Haemostasis|April 8, 1998
Importance of the FcgammaRIIa-Arg/His-131 polymorphism in heparin-induced thrombocytopenia diagnosisC Bachelot-Loza, R Saffroy, D Lasne, et al.
Thrombosis and Haemostasis|February 26, 1982
Kinetic study of factor X during oral anticoagulation with acenocoumarol: potential value for the initiation of treatmentM Aiach, J N Fiessinger, L Capron, et al.
Journal of Thrombosis and Haemostasis : JTH|June 29, 2006
The angiopoietin pathway is modulated by PAR-1 activation on human endothelial progenitor cellsD M Smadja, I Laurendeau, C Avignon, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|January 14, 1973
[Prostate cancer and disseminated intravascular blood coagulation]H Durand, M Aiach, J Belaiche, et al.
Thrombosis and Haemostasis|February 28, 1986
Heparin-associated thrombocytopenia treatment with low molecular weight heparinJ F Vitoux, J F Mathieu, M Roncato, et al.
Transfusion|October 1, 1994
Influence of a 12-hour, 22 degrees C holding period for buffy coats on the preparation of platelet concentrates stored in plasmaN Boeri, S Saleun, E Pelissier, et al.
La Revue De Medecine Interne|May 1, 1986
[Fatal cerebellar embolism during the in situ thrombolytic treatment of an acute arterial obstruction]J F Vitoux, J N Fiessinger, J M Pernès, et al.
Pageof 24